1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model

MLA

Pamela A. Hershberger, et al. “1alpha,25-Dihydroxyvitamin D3 Potentiates Cisplatin Antitumor Activity by P73 Induction in a Squamous Cell Carcinoma Model.” Molecular Cancer Therapeutics, vol. 7, no. 9, Sept. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e8d5c72d5bbcb1a973f2a31e73cd5c7&authtype=sso&custid=ns315887.

APA

Pamela A. Hershberger, Wei-Dong Yu, Rui-Xian Kong, Donald L. Trump, Geraldine Flynn, Yingyu Ma, & Candace S. Johnson. (2008). 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Molecular Cancer Therapeutics, 7(9).

Chicago

Pamela A. Hershberger, Wei-Dong Yu, Rui-Xian Kong, Donald L. Trump, Geraldine Flynn, Yingyu Ma, and Candace S. Johnson. 2008. “1alpha,25-Dihydroxyvitamin D3 Potentiates Cisplatin Antitumor Activity by P73 Induction in a Squamous Cell Carcinoma Model.” Molecular Cancer Therapeutics 7 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e8d5c72d5bbcb1a973f2a31e73cd5c7&authtype=sso&custid=ns315887.